Cargando…

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C

Hepatitis C Virus (HCV) infects 2% of the world’s population and is the leading cause of liver disease and liver transplantation. It poses a serious and growing worldwide public health problem that will only be partially addressed with the introduction of new antiviral therapies. However, these trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masavuli, Makutiro Ghislain, Wijesundara, Danushka K., Torresi, Joseph, Gowans, Eric J., Grubor-Bauk, Branka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723323/ https://www.ncbi.nlm.nih.gov/pubmed/29259601 http://dx.doi.org/10.3389/fmicb.2017.02413

Ejemplares similares

A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2019)

Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines
por: Shrestha, Ashish C., et al.
Publicado: (2019)

Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection
por: Mekonnen, Zelalem A., et al.
Publicado: (2019)

Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1
por: Wijesundara, Danushka K., et al.
Publicado: (2017)

Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus
por: Gummow, Jason, et al.
Publicado: (2020)

Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3
por: Mekonnen, Zelalem A., et al.
Publicado: (2020)

Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine
por: Wijesundara, Danushka K., et al.
Publicado: (2023)

Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses
por: Tomusange, Khamis, et al.
Publicado: (2016)

Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis
por: Canavese, Miriam, et al.
Publicado: (2016)

A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice
por: Tomusange, Khamis, et al.
Publicado: (2016)

Cytolytic DNA vaccine encoding lytic perforin augments the maturation of- and antigen presentation by- dendritic cells in a time-dependent manner
por: Wijesundara, Danushka K., et al.
Publicado: (2017)

Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis
por: Fenix, Kevin, et al.
Publicado: (2020)

Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery
por: Christiansen, D., et al.
Publicado: (2019)

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
por: Torresi, Joseph
Publicado: (2017)

Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein
por: Gargett, Tessa, et al.
Publicado: (2014)

Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates
por: Collett, Simon, et al.
Publicado: (2023)

NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice
por: Grubor-Bauk, B., et al.
Publicado: (2019)

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine
por: Christiansen, D., et al.
Publicado: (2018)

Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19
por: Perkins, Griffith B., et al.
Publicado: (2022)

Unraveling the Convoluted Biological Roles of Type I Interferons in Infection and Immunity: A Way Forward for Therapeutics and Vaccine Design
por: Wijesundara, Danushka Kumara, et al.
Publicado: (2014)

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
por: Ryan, Feargal J., et al.
Publicado: (2022)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents
por: Garcia-Valtanen, Pablo, et al.
Publicado: (2022)

Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients
por: Tunbridge, Matthew, et al.
Publicado: (2022)

Expression, Purification and Characterization of the Hepatitis E Virus Like-Particles in the Pichia pastoris
por: Gupta, Jyoti, et al.
Publicado: (2020)

A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines
por: Ryan, Feargal J., et al.
Publicado: (2023)

Preclinical evaluation of OMVs as potential vaccine candidates against Salmonella enterica serovar Enteritidis infection
por: Jiang, Xi, et al.
Publicado: (2022)

Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity
por: Roy, Sreeja, et al.
Publicado: (2020)

Fear of Influenza Resurgence amid COVID-19 Pandemic: Need for Effective Flu Vaccine Still Exists
por: Wijesundara, Danushka K., et al.
Publicado: (2021)

Bacterial expression systems based on Tymovirus-like particles for the presentation of vaccine antigens
por: Ogrina, Anete, et al.
Publicado: (2023)

Assembly Pathway of Hepatitis B Core Virus-like Particles from Genetically Fused Dimers
por: Holmes, Kris, et al.
Publicado: (2015)

Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
por: Tariq, Hasnat, et al.
Publicado: (2022)

Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis
por: Andersson, Jourdan A., et al.
Publicado: (2017)

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
por: Hwa, Shi-Hsia, et al.
Publicado: (2013)

Preclinical Testing of a Vaccine Candidate against Tularemia
por: Suresh, Ragavan Varadharajan, et al.
Publicado: (2015)

Computational analysis of candidate prion-like proteins in bacteria and their role
por: Iglesias, Valentin, et al.
Publicado: (2015)

Mycobacterial glycoproteins: a novel subset of vaccine candidates
por: Facciuolo, Antonio, et al.
Publicado: (2014)

Novel approaches to identify protective malaria vaccine candidates
por: Chia, Wan Ni, et al.
Publicado: (2014)

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza
por: Williams, Clare M, et al.
Publicado: (2022)

Morphogenesis of Infectious Hepatitis C Virus Particles
por: Suzuki, Tetsuro
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_eak7tltsnifsl0dc92oc5cfufa